These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
3. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609 [TBL] [Abstract][Full Text] [Related]
4. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in enhancement of osteoclast formation by activin-A. Kajita T; Ariyoshi W; Okinaga T; Mitsugi S; Tominaga K; Nishihara T J Cell Biochem; 2018 Aug; 119(8):6974-6985. PubMed ID: 29737562 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ). Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059 [TBL] [Abstract][Full Text] [Related]
7. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis. Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732 [TBL] [Abstract][Full Text] [Related]
10. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180 [TBL] [Abstract][Full Text] [Related]
12. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Huang H; Chang EJ; Ryu J; Lee ZH; Lee Y; Kim HH Biochem Biophys Res Commun; 2006 Dec; 351(1):99-105. PubMed ID: 17052691 [TBL] [Abstract][Full Text] [Related]
13. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790 [TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
15. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway. Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803 [TBL] [Abstract][Full Text] [Related]
16. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway. Omi M; Kaartinen V; Mishina Y J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522 [TBL] [Abstract][Full Text] [Related]
17. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Kim JH; Kim K; Youn BU; Jin HM; Kim N Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061 [TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Ha J; Choi HS; Lee Y; Lee ZH; Kim HH Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574 [TBL] [Abstract][Full Text] [Related]
19. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling. Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233 [TBL] [Abstract][Full Text] [Related]
20. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Tsuji-Naito K Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]